Recommendations
- Bioequivalence and statistics in clinical pharmacology.
- Bioequivalence trials, intersection-union tests and equivalence confidence sets. With comments and a rejoinder by the authors
- scientific article; zbMATH DE number 747024
- On Testing for Bioequivalence
- Design and Analysis of Bioavailability and Bioequivalence Studies
Cited in
(26)- Pilot-pivotal trials for average bioequivalence
- On bilateral selection \(t\) model and its application to inequality constrained problems
- On Testing the Mean Equivalence of Treatments from Correlated Normal Populations
- Biosimilars. Design and analysis of follow-on biologics
- scientific article; zbMATH DE number 6672845 (Why is no real title available?)
- Hypothesis Testing for Equivalence Defined on Symmetric Open Intervals
- Bayesian methods for bioequivalence studies
- Assessing Bioavailablility of Drug Delivery Systems
- Testing the Equivalence of Generalized Variances in Multivariate Bioequivalence
- scientific article; zbMATH DE number 747024 (Why is no real title available?)
- Some factors affecting statistical power of approximate tests in the linear mixed model for longitudinal data
- Analytical similarity assessment in biosimilar product development
- Equivalence of regression curves
- Bioequivalence and statistics in clinical pharmacology.
- On testing the bioequivalence of several treatments using the measure of distance
- Statistical Design and Analysis of Stability Studies
- Design and Analysis of Bioavailability and Bioequivalence Studies
- Iterated bootstrap procedure in individual bioequivalence
- Comparing regression curves: an L^1-point of view
- Power analysis of approximation methods for parameter estimation in Cox regression model with longitudinal covariate and tied survival times
- Similarity of competing risks models with constant intensities in an application to clinical healthcare pathways involving prostate cancer surgery
- Improved test procedure and sample size calculation for assessing similarity in two-group comparative studies with heterogeneous variances
- Two-stage designs for cross-over bioequivalence trials
- Overcoming model uncertainty -- how equivalence tests can benefit from model averaging
- An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses
- Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs
This page was built for publication: Bioequivalence Studies in Drug Development
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5309796)
